• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者的死亡率及死亡原因:芬兰一项全国性登记研究

Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland.

作者信息

Jussila Airi, Virta Lauri J, Pukkala Eero, Färkkilä Martti A

机构信息

Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland; Seinäjoki Central Hospital, Seinäjoki, Finland.

Social Insurance Institution, Research Department, Turku, Finland.

出版信息

J Crohns Colitis. 2014 Sep;8(9):1088-96. doi: 10.1016/j.crohns.2014.02.015. Epub 2014 Mar 12.

DOI:10.1016/j.crohns.2014.02.015
PMID:24630486
Abstract

BACKGROUND AND AIM

Increased mortality has been reported in Crohn's disease (CD) but mostly not in ulcerative colitis (UC). We evaluated the overall and cause-specific mortality in a nationwide cohort of patients with inflammatory bowel disease (IBD) in Finland.

METHODS

A total of 21,964 patients with IBD (16,649 with UC and 5315 with CD) from the Special Reimbursement register were diagnosed 1987-1993 and 2000-2007 and followed up to the end of 2010 by collating these figures with the national computerized Cause-of-Death Register of Statistics Finland. In each cause-of-death category, the number of deaths reported was compared to that expected in general population, and expressed as a standardized mortality ratio (SMR).

RESULTS

Overall mortality was increased among patients with CD (SMR 1.33, 95% confidence interval 1.21-1.46) and UC (1.10, 1.05-1.15). SMR was significantly increased for gastrointestinal causes in CD (6.53, 4.91-8.52) and UC (2.81, 2.32-3.34). Patients with UC were found also to have increased SMR from pulmonary (1.24, 1.02-1.46) and cardiovascular disease (1.14, 1.06-1.22) and cancers of the colon (1.90, 1.38-2.55), rectum (1.79, 1.14-2.69) and biliary tract (5.65, 3.54-8.54), whereas SMR from alcohol-related deaths was decreased (0.54, 0.39-0.71). Patients with CD had a significantly increased SMR for pulmonary diseases (2.01, 1.39-2.80), infections (4.27, 2.13-7.63) and cancers of the biliary tract (4.51, 1.23-11.5) and lymphoid and hematopoietic tissue (2.95, 1.85-4.45).

CONCLUSIONS

In this Finnish nationwide study increased overall mortality in both CD and UC was observed. The excess mortality of 14% in IBD is mainly due to deaths related to inflammation in the gut.

摘要

背景与目的

据报道,克罗恩病(CD)患者的死亡率有所上升,但溃疡性结肠炎(UC)患者大多并非如此。我们评估了芬兰全国范围内炎症性肠病(IBD)患者的总体死亡率和死因特异性死亡率。

方法

从特殊报销登记册中选取了1987 - 1993年及2000 - 2007年被诊断的21964例IBD患者(16649例UC患者和5315例CD患者),并通过将这些数据与芬兰国家计算机化死因登记册进行核对,随访至2010年底。在每个死因类别中,将报告的死亡人数与一般人群预期的死亡人数进行比较,并表示为标准化死亡率(SMR)。

结果

CD患者(SMR 1.33,95%置信区间1.21 - 1.46)和UC患者(1.10,1.05 - 1.15)的总体死亡率均有所上升。CD患者(6.53,4.91 - 8.52)和UC患者(2.81,2.32 - 3.34)因胃肠道原因导致的SMR显著升高。还发现UC患者肺部(1.24,1.02 - 1.46)、心血管疾病(1.14,1.06 - 1.22)以及结肠(1.90,1.38 - 2.55)、直肠(1.79,1.14 - 2.69)和胆道(5.65,3.54 - 8.54)癌症的SMR升高,而与酒精相关死亡的SMR降低(0.54,0.39 - 0.71)。CD患者肺部疾病(2.01,1.39 - 2.80)、感染(4.27,2.13 - 7.63)以及胆道(4.51,1.23 - 11.5)和淋巴及造血组织(2.95,1.85 - 4.45)癌症的SMR显著升高。

结论

在这项芬兰全国性研究中,观察到CD和UC患者的总体死亡率均有所上升。IBD患者14%的额外死亡率主要归因于与肠道炎症相关的死亡。

相似文献

1
Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland.炎症性肠病患者的死亡率及死亡原因:芬兰一项全国性登记研究
J Crohns Colitis. 2014 Sep;8(9):1088-96. doi: 10.1016/j.crohns.2014.02.015. Epub 2014 Mar 12.
2
Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland.溃疡性结肠炎和克罗恩病的死亡率。芬兰的一项基于人群的研究。
J Crohns Colitis. 2012 Jun;6(5):524-8. doi: 10.1016/j.crohns.2011.10.009. Epub 2011 Nov 16.
3
Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.炎症性肠病患者的恶性肿瘤:芬兰一项全国性登记研究
Scand J Gastroenterol. 2013 Dec;48(12):1405-13. doi: 10.3109/00365521.2013.846402. Epub 2013 Oct 16.
4
Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.炎症性肠病患者的生存情况及死因特异性死亡率:明尼苏达州奥姆斯特德县1940 - 2004年的长期结局研究
Gut. 2006 Sep;55(9):1248-54. doi: 10.1136/gut.2005.079350. Epub 2006 Jan 19.
5
Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort.荷兰 1991-2002 年炎症性肠病死亡率:一项基于人群的研究结果:IBD 南林堡队列。
Inflamm Bowel Dis. 2010 Aug;16(8):1397-410. doi: 10.1002/ibd.21189.
6
Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.首次因炎症性肠病住院后的死亡率:一项全国性登记研究。
Inflamm Bowel Dis. 2019 Sep 18;25(10):1692-1699. doi: 10.1093/ibd/izz055.
7
Ulcerative colitis and colorectal cancer: a follow-up study in Fukuoka, Japan.溃疡性结肠炎与结直肠癌:日本福冈的一项随访研究
Int J Epidemiol. 1999 Aug;28(4):609-13. doi: 10.1093/ije/28.4.609.
8
The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.芬兰炎症性肠病患者的结直肠癌风险:20 年随访。
J Crohns Colitis. 2013 Dec;7(11):e551-7. doi: 10.1016/j.crohns.2013.04.003. Epub 2013 Apr 23.
9
Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland.2000 年至 2007 年期间炎症性肠病发病率的上升:芬兰全国登记研究。
Inflamm Bowel Dis. 2012 Mar;18(3):555-61. doi: 10.1002/ibd.21695. Epub 2011 Mar 18.
10
Mortality in inflammatory bowel disease patients under 65 years of age.65岁以下炎症性肠病患者的死亡率
Scand J Gastroenterol. 2014 Jul;49(7):814-9. doi: 10.3109/00365521.2014.907824. Epub 2014 Apr 14.

引用本文的文献

1
Mendelian randomization analysis reveals genetic evidence for a causal link between inflammatory bowel disease and uterine cervical neoplasms.孟德尔随机化分析揭示了炎症性肠病与子宫颈肿瘤之间因果关系的遗传证据。
Front Genet. 2025 Jan 28;15:1436512. doi: 10.3389/fgene.2024.1436512. eCollection 2024.
2
Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019.中东和北非地区炎症性肠病负担:1990年至2019年发病率、患病率及死亡率的综合分析
Ann Gastroenterol. 2024 Sep-Oct;37(5):527-535. doi: 10.20524/aog.2024.0909. Epub 2024 Aug 19.
3
Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study.
炎症性肠病中支气管扩张风险增加及相关危险因素:一项为期10年的韩国全国队列研究
ERJ Open Res. 2024 Jul 22;10(4). doi: 10.1183/23120541.00087-2024. eCollection 2024 Jul.
4
High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.高 iNOS 和 IL-1β 免疫反应是结肠炎相关结直肠癌肿瘤的特征,但不能预测 5 年生存率。
Ups J Med Sci. 2024 Jan 2;28. doi: 10.48101/ujms.v128.10241. eCollection 2023.
5
Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study.炎症性肠病与 32 个特定部位的结外癌症之间的因果关联:一项孟德尔随机化研究。
BMC Med. 2023 Oct 10;21(1):389. doi: 10.1186/s12916-023-03096-y.
6
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.IBD 患者感染 COVID-19 的风险因居住在城市而增加,且与疾病活动或静脉内生物制剂无关。
Front Immunol. 2023 Aug 28;14:1243898. doi: 10.3389/fimmu.2023.1243898. eCollection 2023.
7
Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population.炎症性肠病患者中的结直肠癌:与普通人群相比的风险因素和患病率
Front Med (Lausanne). 2023 Aug 7;10:1225616. doi: 10.3389/fmed.2023.1225616. eCollection 2023.
8
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review.女性性别在炎症性肠病中的影响:一项叙述性综述
J Pers Med. 2023 Jan 17;13(2):165. doi: 10.3390/jpm13020165.
9
Association of inflammatory bowel disease and related medication exposure with risk of Alzheimer's disease: An updated meta-analysis.炎症性肠病及相关药物暴露与阿尔茨海默病风险的关联:一项更新的荟萃分析。
Front Aging Neurosci. 2023 Jan 12;14:1082575. doi: 10.3389/fnagi.2022.1082575. eCollection 2022.
10
Substance abuse and inpatient outcomes in inflammatory bowel disease hospitalizations in the United States: a propensity matched analysis.美国炎症性肠病住院患者的药物滥用与住院结局:一项倾向匹配分析
Ann Gastroenterol. 2023 Jan-Feb;36(1):32-38. doi: 10.20524/aog.2022.0767. Epub 2022 Nov 29.